Pandemic threat to telco and IT industry Read more about Pandemic threat to telco and IT industry3 views
Commentary on “Vaccines for preventing influenza in healthy children”, with responses from the review authors and from the editors of Evidence-Based Child Health Read more about Commentary on “Vaccines for preventing influenza in healthy children”, with responses from the review authors and from the editors of Evidence-Based Child Health
Bird flu: pandemic flu is not just about probability [letter] Read more about Bird flu: pandemic flu is not just about probability [letter] 9 views
Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts Read more about Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts39 views
Influenza related hospitalisations in Sydney, New South Wales, Australia Read more about Influenza related hospitalisations in Sydney, New South Wales, Australia1 view
Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria Read more about Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria19 views
Influenza vaccines in healthy children [letter] Read more about Influenza vaccines in healthy children [letter] 1 view
Prevalence and determinants of influenza vaccination in Australians aged 40 years and over – a national survey Read more about Prevalence and determinants of influenza vaccination in Australians aged 40 years and over – a national survey3 views
Influenza A associated morbidity and mortality in a paediatric intensive care unit Read more about Influenza A associated morbidity and mortality in a paediatric intensive care unit3 views
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old Read more about Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old7 views
